Securian Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.12M | Hold |
2,741
| – | – | 0.08% | 156 |
|
|
2025
Q4 | $2.12M | Sell |
2,741
-2,235
| -45% | -$1.52M | 0.08% | 153 |
|
|
2025
Q3 | $2.8M | Sell |
4,976
-458
| -8% | -$259K | 0.07% | 199 |
|
|
2025
Q2 | $2.85M | Sell |
5,434
-213
| -4% | -$119K | 0.08% | 197 |
|
|
2025
Q1 | $3.58M | Hold |
5,647
| – | – | 0.11% | 161 |
|
|
2024
Q4 | $4.02M | Sell |
5,647
-250
| -4% | -$210K | 0.12% | 144 |
|
|
2024
Q3 | $6.2M | Sell |
5,897
-250
| -4% | -$278K | 0.18% | 98 |
|
|
2024
Q2 | $6.46M | Sell |
6,147
-67
| -1% | -$65K | 0.19% | 97 |
|
|
2024
Q1 | $5.98M | Sell |
6,214
-616
| -9% | -$586K | 0.18% | 109 |
|
|
2023
Q4 | $6M | Sell |
6,830
-882
| -11% | -$726K | 0.17% | 110 |
|
|
2023
Q3 | $6.35M | Sell |
7,712
-1,378
| -15% | -$1.08M | 0.19% | 101 |
|
|
2023
Q2 | $6.53M | Sell |
9,090
-80
| -0.9% | -$61.7K | 0.17% | 112 |
|
|
2023
Q1 | $7.53M | Buy |
9,170
+90
| +1% | +$67.9K | 0.2% | 102 |
|
|
2022
Q4 | $6.55M | Sell |
9,080
-75
| -0.8% | -$55.3K | 0.18% | 110 |
|
|
2022
Q3 | $6.31M | Sell |
9,155
-40
| -0.4% | -$25.2K | 0.19% | 98 |
|
|
2022
Q2 | $5.43M | Hold |
9,195
| – | – | 0.13% | 165 |
|
|
2022
Q1 | $6.42M | Buy |
9,195
+100
| +1% | +$63.3K | 0.13% | 165 |
|
|
2021
Q4 | $5.74M | Sell |
9,095
-100
| -1% | -$61.5K | 0.11% | 186 |
|
|
2021
Q3 | $5.57M | Sell |
9,195
-100
| -1% | -$62.1K | 0.11% | 181 |
|
|
2021
Q2 | $5.19M | Hold |
9,295
| – | – | 0.11% | 192 |
|
|
2021
Q1 | $4.4M | Sell |
9,295
-315
| -3% | -$153K | 0.1% | 214 |
|
|
2020
Q4 | $4.64M | Sell |
9,610
-40
| -0.4% | -$21.6K | 0.11% | 207 |
|
|
2020
Q3 | $5.4M | Buy |
9,650
+143
| +2% | +$86.7K | 0.13% | 165 |
|
|
2020
Q2 | $5.93M | Buy |
9,507
+1,486
| +19% | +$843K | 0.15% | 144 |
|
|
2020
Q1 | $3.92M | Sell |
8,021
-100
| -1% | -$41.2K | 0.11% | 192 |
|
|
2019
Q4 | $3.05M | Sell |
8,121
-197
| -2% | -$66.3K | 0.07% | 278 |
|
|
2019
Q3 | $2.31M | Buy |
8,318
+100
| +1% | +$29.6K | 0.05% | 334 |
|
|
2019
Q2 | $2.57M | Buy |
8,218
+7
| +0.1% | +$2.33K | 0.06% | 303 |
|
|
2019
Q1 | $3.37M | Buy |
8,211
+211
| +3% | +$86.9K | 0.08% | 245 |
|
|
2018
Q4 | $2.99M | Buy |
8,000
+15
| +0.2% | +$5.49K | 0.08% | 242 |
|
|
2018
Q3 | $3.23M | Sell |
7,985
-100
| -1% | -$38.1K | 0.08% | 249 |
|
|
2018
Q2 | $2.79M | Hold |
8,085
| – | – | 0.07% | 272 |
|
|
2018
Q1 | $2.78M | Hold |
8,085
| – | – | 0.07% | 272 |
|
|
2017
Q4 | $3.04M | Buy |
8,085
+200
| +3% | +$81K | 0.08% | 257 |
|
|
2017
Q3 | $3.53M | Buy |
7,885
+148
| +2% | +$70.4K | 0.09% | 219 |
|
|
2017
Q2 | $3.8M | Sell |
7,737
-110
| -1% | -$48.1K | 0.1% | 210 |
|
|
2017
Q1 | $3.04M | Buy |
7,847
+200
| +3% | +$74.1K | 0.08% | 235 |
|
|
2016
Q4 | $2.81M | Buy |
7,647
+100
| +1% | +$38K | 0.08% | 256 |
|
|
2016
Q3 | $3.03M | Sell |
7,547
-354
| -4% | -$142K | 0.08% | 234 |
|
|
2016
Q2 | $2.76M | Buy |
7,901
+100
| +1% | +$38.5K | 0.08% | 242 |
|
|
2016
Q1 | $2.81M | Buy |
7,801
+200
| +3% | +$82.4K | 0.08% | 234 |
|
|
2015
Q4 | $4.13M | Buy |
7,601
+179
| +2% | +$97K | 0.12% | 174 |
|
|
2015
Q3 | $3.45M | Buy |
7,422
+100
| +1% | +$53.7K | 0.11% | 183 |
|
|
2015
Q2 | $3.73M | Buy |
7,322
+200
| +3% | +$97.6K | 0.12% | 185 |
|
|
2015
Q1 | $3.21M | Buy |
7,122
+300
| +4% | +$127K | 0.09% | 216 |
|
|
2014
Q4 | $2.8M | Buy |
6,822
+300
| +5% | +$118K | 0.09% | 228 |
|
|
2014
Q3 | $2.35M | Sell |
6,522
-708
| -10% | -$237K | 0.08% | 251 |
|
|
2014
Q2 | $2.04M | Hold |
7,230
| – | – | 0.07% | 264 |
|
|
2014
Q1 | $2.17M | Buy |
7,230
+100
| +1% | +$30.8K | 0.08% | 245 |
|
|
2013
Q4 | $1.96M | Buy |
7,130
+100
| +1% | +$28.8K | 0.07% | 269 |
|
|
2013
Q3 | $2.2M | Buy |
7,030
+300
| +4% | +$78.9K | 0.09% | 227 |
|
|
2013
Q2 | $1.51M | Buy |
+6,730
| New | +$1.57M | 0.06% | 281 |
|
Other funds holding REGN
VCM
N
Securian Asset Management's REGN Position: Q1 2026 in Review
Securian Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 2,741 shares worth $2.12M. The position accounts for 0.08% of the portfolio, ranked #156.
Securian Asset Management first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.53M in Q1 2023. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Securian Asset Management held 2,741 shares of Regeneron Pharmaceuticals worth $2.12M as of Q1 2026.
- Securian Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
- Regeneron Pharmaceuticals made up 0.08% of Securian Asset Management's portfolio in Q1 2026, its #156 holding.
- Securian Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Securian Asset Management's Regeneron Pharmaceuticals position peaked at $7.53M in Q1 2023.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Securian Asset Management's 13F filing for Q1 2026, filed 1 May 2026.